Patent · US Active

Oridonin analogs, compositions, and methods related thereto

US10072022B2 · kind B2 · utility

0Cited by

0References

8Claims

0Family size

Assignee

The Board of Regents of the University of Texas System · US

Inventors

Jia Zhou · Galveston, US
Chunyong Ding · Shanghai, CN
Qiang Shen · Ottawa, CA

Key dates

Filing date	Jun 28, 2017
Grant date	Sep 11, 2018
Priority date	—
Expiry date	Jun 28, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D515/08
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Certain embodiments are directed to oridonin analogs or derivatives. In certain aspects, the derivatives are used as anticancer or anti-inflammatory agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.